摘要
肺癌已成为绝大多数国家主要癌症死亡原因,早期诊断和早期治疗尤为重要。肺癌的发生是多因素致病、多基因参与和多阶段发展的复杂过程,近年来国内外学者对有关肺癌早期诊断的分子标志物做了大量有益的探索。本文将近年来肺癌早期实验室诊断的方法及进展做一综述。
Lung cancer is the most common cause of cancer death worldwide. Early diagnosis and early treat- ment are of great importance. Lung cancer is a multi-factorial disease, and multiple genes involved in the de- velopment of complex multi-stage process. In recent years, domestic and foreign scholars on the early diagnosis of lung cancer biomarkers have done a lot of useful exploration. In this paper, recent developments in this field are reviewed.
出处
《标记免疫分析与临床》
CAS
2013年第5期336-339,347,共5页
Labeled Immunoassays and Clinical Medicine
关键词
肺癌
早期诊断
标志物
Lung cancer
Early diagnosis
Markers
作者简介
沈迪（1983一），女，在读硕士，主治医师，从事临床检验诊断工作。Tel：010—87788746；E—mail：sweetsmile976@sohu．com．
